It is with great pleasure that Sakura Finetek Europe announces the appointment of Jaap Stuut as the President and General Manager, effective today. Jaap will lead the EMEAI division in this pivotal role, shaping the company's mission, vision, and long-term strategy.

Jaap brings a wealth of experience to Sakura Finetek Europe, having served as CEO of Immunodiagnostics Systems (IDS) since 2017. With over a decade of executive experience, Jaap is highly skilled in market strategy, organisational development, and regulatory compliance, particularly in IVDR.

Before his leadership at IDS, Jaap held vital positions at Novartis and Roche Diagnostics, demonstrating his expertise in strategic management and business development within the healthcare sector.

Jaap studied Medicine at the University of Groningen and holds a Master of Business Administration from the NIMBAS School of Management, University of Bradford. He has refined his skills through executive programs at esteemed institutions such as the London Business School and Harvard Business School.

Born and raised in the Netherlands, Jaap is a native Dutch speaker with professional fluency in English and German. He will be based at Sakura Finetek Europe's Central Office in Alphen aan den Rijn.

"We are thrilled to welcome Jaap Stuut to Sakura Finetek Europe as our new President and General Manager," said Andries Dragt, Vice President of Strategy & Innovation at Sakura Finetek Europe. "Jaap's extensive experience and strategic vision make him an ideal leader to guide our company. We are confident that Sakura Finetek Europe will achieve even greater success under his leadership in the future."

Join us in extending a warm welcome to Jaap as he embarks on this exciting journey with Sakura Finetek Europe.

About Sakura Finetek Europe:

Sakura Finetek Europe is a leading provider of advanced technologies and solutions in anatomical pathology. With a commitment to innovation and excellence, Sakura Finetek Europe empowers healthcare professionals worldwide to deliver accurate diagnoses and improve patient outcomes.